RainDance Technologies has opened a patent infringement case against 10X Genomics. The suit alleges that 10X Genomics--which exited stealth mode and raised $55.5 million last month--is using tech protected by patents licensed to RainDance from the University of Chicago. 10X Genomics has hit back against the claims. "We are firmly of the view that our products do not infringe any claims of any of the asserted patents," CEO Serge Saxonov said in a statement. Release | More